Summary

This article discusses two analyses from the Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycemia in Diabetes study [RECORD; NCT00379769; Home PD et al. Lancet 2009] of cardiovascular outcomes in patients who were treated with rosiglitazone.

  • Diabetes Mellitus
  • Diabetes & Endocrinology Clinical Trials Clinical Trials
View Full Text